Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Therapy in Prosthetic Joint Infections
NCT04787250Phase 2Withdrawn
- Sponsor
- BiomX
- Start
- Oct 2022
- Primary completion
- May 2023
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of PhageBank in prosthetic joint infection (PJI), sponsored by BiomX. Planned start Oct 2022; status: withdrawn.
02
Drugs
PhageBank
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04787250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04787250.